Unknown

Dataset Information

0

Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments.


ABSTRACT: Phosphorylation of l-serine-containing enkephalin analogs has been explored as an alternative to glycosylation in an effort to increase blood-brain barrier permeability and CNS bioavailability of peptide pharmacophores. Two enkephalin-based peptides were modified for these studies, a set related to DTLES, a mixed ?/?-agonist, and one related to DAMGO, a highly selective ?-agonist. Each unglycosylated peptide was compared to its phosphate, its mono-benzylphosphate ester, and its ?-d-glucoside. Binding was characterized in membrane preparations from Chinese hamster ovary cells expressing human ?, ? and ?-opiate receptors. Antinociception was measured in mice using the 55 °C tail-flick assay. To estimate bioavailability, the antinociceptive effect of each opioid agonist was evaluated after intracerebroventricular (i.c.v.) or intravenous administration (i.v.) of the peptides. Circular dichroism methods and high-field nuclear magnetic resonance were used in the presence and absence of sodium dodecylsulfate to understand how the presence of a membrane might influence the peptide conformations.

SUBMITTER: Yeomans L 

PROVIDER: S-EPMC3193572 | biostudies-literature | 2011 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phosphorylation of enkephalins: NMR and CD studies in aqueous and membrane-mimicking environments.

Yeomans Larisa L   Muthu Dhanasekaran D   Lowery John J JJ   Martinez Heather N HN   Abrell Leif L   Lin Guanxin G   Strom Kyle K   Knapp Brian I BI   Bidlack Jean M JM   Bilsky Edward J EJ   Polt Robin R  

Chemical biology & drug design 20110926 5


Phosphorylation of l-serine-containing enkephalin analogs has been explored as an alternative to glycosylation in an effort to increase blood-brain barrier permeability and CNS bioavailability of peptide pharmacophores. Two enkephalin-based peptides were modified for these studies, a set related to DTLES, a mixed μ/δ-agonist, and one related to DAMGO, a highly selective μ-agonist. Each unglycosylated peptide was compared to its phosphate, its mono-benzylphosphate ester, and its β-d-glucoside. Bi  ...[more]

Similar Datasets

| S-EPMC6827292 | biostudies-literature
| S-EPMC9696787 | biostudies-literature
| S-EPMC5047179 | biostudies-literature
| S-EPMC5627949 | biostudies-literature
| S-EPMC4628624 | biostudies-literature
| S-EPMC1157056 | biostudies-literature
| S-EPMC4380506 | biostudies-literature
| S-EPMC7662265 | biostudies-literature
| S-EPMC4183644 | biostudies-literature
| S-EPMC6109379 | biostudies-literature